Eli Lilly Stops Antibody Trial In Hospitalized Covid-19 Patients

Is this a sign that monoclonal antibodies against SARS-CoV-2 are an ineffective treatment? Not necessarily.

Read the full post on Forbes - Healthcare

William A. Haseltine, Contributor